発表論文(国際)

2024-02.

Arata M, Tamura K, Aoki H, Noguchi H, Takeda A, Minato S, Yamamoto S, Kinouchi R, Yoshida K, Yamamoto Y, Kaji T, Iwasa T: The Effects of Testosterone on Hypothalamic and Serum Oxytocin Levels Are Affected by the Estrogen Milieu in Female Rats. Nutrients. 2024 Aug 2;16(15):2533. ［5Y-IF: 5.8］

2024-03.

Ban H, Miura K, Ando T, Shirai Y, Kaneko N, Ishizuka K, Hotta K, Mattori M: Clinical Course of Nonresponders With Recurrent Focal Segmental Glomerulosclerosis After Pediatric Kidney Transplantation: A Retrospective Multicenter Study. Pediatr Transplant. 2024 Aug;28(5):e14809. ［5Y-IF: 1.5］

2024-04.

Ebina K, Abe T, Higuchi M, Hotta K, Furumido J, Iwahara N, Senoo T, Komizunai S, Tsujita T, Sase K, Chen X, Kurashima Y, Kikuchi H, Miyata H, Matsumoto R, Osawa T, Murai S, Konno A, Shinohara N: Surgical skill analysis focused on tissue traction in laparoscopic wet lab training. Surg Open Sci. 2024 Aug 22:21:7-13.［5Y-IF: 1.3］

2024-05.

Ebina K, Abe T, Yan L, Hotta K, Kamijo C, Higuchi M, Kon M, Kikuchi H, Miyata H, Matsumoto R, Osawa T, Murai S, Kurashima Y, Shichinohe T, Watanabe M, Komizunai S, Tsujita T, Sase K, Chen X, Senoo T, Shinohara N, Konno A: Development of a hybrid measurement system for surgical instrument motion of laparoscopic surgery. IEEE Transactions on medical robotics and bionics. Epub 2025 Mar 12.［5Y-IF: N/A］

2024-06.

Ebina K, Abe T, Yan L, Hotta K, Shichinohe T, Higuchi M, Iwahara N, Hosaka Y, Harada S, Kikuchi H, Miyata H, Matsumoto R, Osawa T, Kurashima Y, Watanabe M, Kon M, Murai S, Komizunai S, Tsujita T, Sase K, Chen X, Senoo T, Shinohara N, Konno A: A surgical instrument motion measurement system for skill evaluation in practical laparoscopic surgery training. PLoS One. 2024 Jun 25;19(6):e0305693. 2024.［5Y-IF: 3.3］

2024-07.

Furumido J, Ozaki N, Matsugase Y, Mori T: Evaluation of Learning Curves for Contact Laser Vaporization of the Prostate using the 980 nm Diode Laser for Benign Prostatic Hyperplasia. Int J Urol. 2024 Aug;31(8):921-926.［5Y-IF: 2.4］

2024-08.

Hara S, Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group.: Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy. Int J Urol. Epub 2025 Feb 5. ［5Y-IF: 2.4］

2024-09.

Harada S, Abe T, Furumido J, Takahashi K, Hori K, Abe N, Kon M, Murai S, Miyata H, Kikuchi H, Matsumoto R, Osawa T, Shinohara N: A prospective study of surgeons’ workloads and associated factors in real-world practice. Sci Rep. 2024 Apr 28;14(1):9741. ［5Y-IF: 4.3］

2024-10.

Hirose T, Hotta K, Osawa T, Yokota I, Inao T, Tanabe T, Iwahara N, Shinohara N: Longitudinal mortality risks and kidney functional outcomes in Japanese living kidney donors. Int J Urol. 2024 May;31(5):519-524.［5Y-IF: 2.4］

2024-11.

Hori K, Abe T, Abe N, Abe J, Okada K, Takahashi K, Harada S, Furumido J, Murai S, Kon M, Hashimoto K, Masumori N, Kakizaki H, Shinohara N: Gap analysis between trainees’ subjective competencies and the competencies expected by instructors in urology: A need assessment survey in Japan. Int J Urol. 2024 Jun;31(6):653-661. ［5Y-IF: 2.4］

2024-12.

Hori K, Yamada S, Murata K, Miyata H, Mizue Y, Murai A, Minowa T, Sasaki K, Shijubou N, Kubo T, Morita R, Tokita S, Kanaseki T, Tsukahara T, Abe T, Shinohara N, Hirohashi Y, Torigoe T: Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization. Hum Vaccin Immunother. 2024 Dec 31;20(1):2414542. ［5Y-IF: 4.2］

2024-13.

Hoshi T, Hirose T, Fuyama K, Iwahara N, Chiba H, Hotta K: Successful kidney transplantation improves atrophic bladder capacity and function within 3 months in long-term dialysis patients. Int J Urol. 2025 Jan;32(1):118-120. ［5Y-IF: 2.4］

2024-14.

Hotta K, Miura M, Tanaka T, Tanabe T, Masumori N, Shinohara N: Surgical strategy for orthotopic kidney transplantation. Int J Urol. 2024 May;31(5):582-584.［5Y-IF: 2.4］

2024-15.

Ikeda A, Yamaguchi T, Ait Bamai Y, Roggeman M, Ikenaka Y, Zeng Y, Yasuda A, Ketema RM, Marsela M, Gys C, den Ouden F, Itoh S, Nakamura A, Kitta T, Kon M, Manabe A, Covaci A, Kishi R: Phosphate Flame Retardants and Plasticizers and Their Association with Reproductive and Steroid Hormone Levels among Peripubertal-Aged Children: The Hokkaido Birth Cohort Study. Environ Sci Technol. 2025 Mar 18;59(10):4820-4831. ［5Y-IF: 11.6］

2024-16.

Ishihara S, Hirose T, Hotta K, Iwahara N, Shinohara N: Inadequate effect of rituximab alone as desensitization to kidney transplant recipients with low titer of preformed donor-specific ant-HLA antibodies. Int J Urol. 2025 Mar;32(3):317-319. ［5Y-IF: 2.4］

2024-17.

Ishii Y, Fukui-Miyazaki A, Iwasaki S, Tsuji T, Hotta K, Sasaki H, Nakagawa S, Yoshida T, Murata E, Taniguchi K, Shinohara N, Ishizu A, Kasahara M, Tomaru U: Impaired immunoproteasomal function exacerbates renal ischemia-reperfusion injury. Exp Mol Pathol. 2024 Dec;140:104939. ［5Y-IF: 2.7］

2024-18.

Iwahara N, Hotta K, Hirose T, Okada H, Shinohara N: Protocol biopsy of kidney allograft enables early detection of BK virus nephropathy to preserve kidney allograft function. Transpl Infect Dis. 2024 Oct;26(5):e14338. ［5Y-IF: 2.1］

2024-19.

Kadota Y, Kato T, Kasai K, Kawakita T, Murayama M, Shinya A, Sasada H, Katayama S, Nii M, Yamamoto S, Noguchi H, Tamura K, Aoki H, Taniguchi M, Nakagawa T, Kaji T, Nishimura M, Kinouchi R, Yoshida K, Iwasa T: Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model. Endocr J. 2024 Apr 30;71(4):395-401. ［5Y-IF: 1.7］

2024-20.

Kamada S, Noguchi H, Yamamoto S, Tamura K, Aoki H, Takeda A, Uchishiba M, Minato S, Arata M, Arakaki R, Inui H, Kagawa T, Kawakita T, Yoshida A, Mineda A, Yamamoto Y, Kinouchi R, Yoshida K, Kaji T, Nishimura M, Iwasa T: Stress responses to bacterial and viral mimetics in polycystic ovary syndrome model rats. Brain Behav Immun Health. 2024 Apr 9:38:100772. ［5Y-IF: N/A］

2024-21.

Kanno T, Ito K, Kita Y, Mochizuki T, Sano T, Yokomizo A, Abe T, Tsuchihashi K, Tatarano S, Inokuchi J, Takahashi A, Matsui Y, Nishiyama H, Kitamura H, Saito R, Kobayashi T; Japan Urological Oncology Group.: Impact of lymph node dissection during surgery on the efficacy of pembrolizumab in patients with metastatic urothelial carcinoma. Int J Urol. Epub 2025 Feb 10. ［5Y-IF: 2.4］

2024-22.

Kashiwagi E, Hatano T, Shimizu K, Takamoto A, Tomita Koji, Osawa T, Sakuhara Y, Hongo F, Hirota T, Ushijima Y, Asayama Y, Goto S, Miki J, Matsukawa A, Kiyomi F, Egawa Shin, Nasu Y, Shinohara N, Ukimura O, Nakano S, Arai Y, Eto M: Safety and Efficacy of Cryotherapy for the Treatment of Renal Angiomyolipoma Related to Tuberous Sclerosis Complex: The Cryo-TSC Study. JU Open Plus. 2024 June; 2(6):e00051,［5Y-IF: N/A］

2024-23.

Kato M, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Yamamoto S, Matsue T, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Uchida J; Japan Urological Oncology Group.: Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study. Int J Clin Oncol. 2024 Dec;29(12):1937-1945. ［5Y-IF: 2.8］

2024-24.

Kato T, Matsumoto R, Yokomizo A, Tohi Y, Fukuhara H, Fujii Y, Mori K, Sato T, Inokuchi J, Hashine K, Sakamoto S, Kinoshita H, Inoue K, Tanikawa T, Utsumi T, Goto T, Hara I, Okuno H, Kakehi Y, Sugimoto M: Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN). BJU Int. 2024 Oct;134(4):652-658. ［5Y-IF: 4.5］

2024-25.

Kawai T, Matsuyama H, Kobayashi K, Ikeda A, Miyake M, Nishimoto K, Matsushita Y, Nishiyama H, Fujimoto K, Oyama M, Miyake H, Azuma H, Inoue K, Mitsui T, Kawakita M, Oyama C, Mizokami A, Abe T, Kuroiwa H, Kume H: Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study). Int J Urol. 2024 Aug;31(8):906-912. ［5Y-IF: 2.4］

2024-26.

Kawashiro K, Suzuki R, Nogimori T, Tsujino S, Iwahara N, Hirose T, Okada K, Yamamoto T, Fukuhara T, Hotta K, Shinohara N: Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients. Sci Rep. 2024 May 28;14(1):12176. ［5Y-IF: 4.3］

2024-27.

Kikuchi H, Osawa T, Matsushita Y, Kojima T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Ueda K, Tanaka H, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Kato T, Hara H, Ito Y, Kitamura H, Miyake H, Shinohara N: Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study. Jpn J Clin Oncol. Epub 2025 February 02. ［5Y-IF: 2.4］

2024-28.

Kimura G, Fujii Y, Honda K, Osawa T, Uchitomi Y, Kondo M, Otani A, Wako T, Kawai D, Mitsuda Y, Sakashita N, Shinohara N: Financial Toxicity in Japanese Patients with Metastatic Renal Cell Carcinoma: A Cross-Sectional Study. Cancers (Basel). 2024 May 16;16(10):1904. ［5Y-IF: 4.9］

2024-29.

Kimura G, Fujii Y, Osawa T, Uchitomi Y, Honda K, Kondo M, Otani A, Wako T, Kawai D, Mitsuda Y, Sakashita N, Shinohara N: Cross-sectional study of therapy-related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan. Cancer Med. 2024 Jun;13(11):e7196. ［5Y-IF: 3.9］

2024-30.

Kita Y, Otsuka H, Ito K, Hara T, Shimura S, Kawahara T, Kato M, Kanamaru S, Inoue K, Ito H, Igarashi A, Sazuka T, Takamatsu D, Hashimoto K, Abe T, Naito S, Matsui Y, Nishiyama H, Kitamura H, Kobayashi T; Japan Urological Oncology Group: Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. Int J Urol. 2024 May;31(5):552-559.［5Y-IF: 2.4］

2024-31.

Matsubara N, Osawa T, Abe T, Oya M, Nishimoto K, Iwahori T, Tsuchiya H, Murota M, Yoshida M, Tatematsu Y, Nakano Y, Eto M, Nonomura N: FGFR2/3 Gene Alterations and Clinical Outcomes in Advanced/Metastatic Urothelial Cancer in Japan: MONSTAR-SCREEN Database Study. Cancer Sci. Epub 2025 Feb 11. ［5Y-IF: 5.5］

2024-32.

Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y; Japanese Urological Oncology Group.: Prognostic impact of histological discordance between transurethral resection and radical cystectomy. BJU Int. 2024 Aug;134(2):207-218. ［5Y-IF: 4.5］

2024-33.

Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Nishiyama N, Kimura T, Yamashita S, Kitamura H, Miyake H; Japanese Urological Oncology Group: Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. Int J Urol. 2024 May;31(5):526-533. ［5Y-IF: 2.4］

2024-34.

Miyamoto M, Nakamura A, Miya A, Nomoto H, Kameda H, Cho KY, Iwahara N, Hotta K, Shinohara N, Atsumi T: Normalization of impaired glucose tolerance after kidney transplantation is associated with improved β-cell function. Am J Physiol Endocrinol Metab. 2024 Aug 1;327(2):E194-E202. ［5Y-IF: 4.5］

2024-35.

Murakami T, Minami K, Harabayashi T, Maruyama S, Takada N, Kashiwagi A, Miyata H, Sato Y, Matsumoto R, Kikuchi H, Abe T, Ito YM, Murai S, Shinohara N, Harada H, Osawa T: Cross-sectional and longitudinal analyses of urinary extracellular vesicle mRNA markers in urothelial bladder cancer patients. Sci Rep. 2024 Mar 21;14(1):6801. ［5Y-IF: 4.3］

2024-36.

Muranishi Y, Itonaga T, Ihara K, Katoh-Fukui Y, Tamaoka S, Hattori A, Kon M, Shinohara N, Fukami M: PTPN11 and FLNA variants in a boy with ambiguous genitalia, short stature, and non-specific dysmorphic features. Clin Pediatr Endocrinol. 2024;33(3):169-173. ［5Y-IF: 1.2］

2024-37.

Muranishi Y, Katoh-Fukui Y, Hattori A, Kobori Y, Osaka A, Okada H, Iwahata T, Kon M, Shinohara N, Fukami M: Compound heterozygous KCTD19 variants in a man with isolated nonobstructive azoospermia. Reprod Med Biol. 2024 Sep 24;23(1):e12608. ［5Y-IF: 3.5］

2024-38.

Muranishi Y, Kobori Y, Katoh-Fukui Y, Tamaoka S, Hattori A, Osaka A, Okada H, Nakabayashi K, Hata K, Kawai T, Ogata-Kawata H, Iwahata T, Saito K, Kon M, Shinohara N, Fukami M: Systematic molecular analyses for 115 karyotypically normal men with isolated non-obstructive azoospermia. Hum Reprod. 2024 May 2;39(5):1131-1140. ［5Y-IF: 6.4］

2024-39.

Naito Z, Wada M, Shichinohe T, Yoshida A, Osawa T, Abe T, Hirano S: Internal Hernia Beneath the Obturator Nerve After Robot-Assisted Radical Cystectomy and Pelvic Lymphadenectomy: A Case Report With Literature Review. Asian J Endosc Surg. 2025 Jan-Dec;18(1):e70030. ［5Y-IF: 1.0］

2024-40.

Nishioka N, Fujima N, Tsuneta S, Yoshikawa M, Kimura R, Sakamoto K, Kato F, Miyata H, Kikuchi H, Matsumoto R, Abe T, Kwon J, Yoneyama M, Kudo K: Enhancing the image quality of prostate diffusion-weighted imaging in patients with prostate cancer through model-based deep learning reconstruction. Eur J Radiol Open. 2024 Jul 5;13:100588. ［5Y-IF: 1.9］

2024-41.

Nishiyama H, Yonese J, Kawahara T, Matsumoto R, Miyake H, Matsubara N, Uemura H, Eto M, Azuma H, Obara W, Terai A, Fukasawa S, Suekane S: TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma. Mol Cancer Ther. 2024 Apr 2; 23(4):532-540. ［5Y-IF: 5.4］

2024-42.

Numakura K, Sekine Y, Osawa T, Naito S, Tokairin O, Muto Y, Sobu R, Kobayashi M, Sasagawa H, Yamamoto R, Nara T, Saito M, Narita S, Akashi H, Tsuchiya N, Shinohara N, Habuchi T: The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy. Int J Clin Oncol. 2024;29(7):1019-26. ［5Y-IF: 2.8］

2024-43.

Ohba K, Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Minami K, Nakai Y, Ueda K, Naito S, Nonomura N, Murai S, Nishiyama H, Nakanishi H, Mukae Y, Mitsunari K, Matsuo T, Imamura R, Shinohara N: Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment. Int J Clin Oncol. Epub 2025 Feb 14. ［5Y-IF: 2.8］

2024-44.

Osawa T, Sasaki K, Machida R, Matsumoto T, Matsui Y, Kitamura H, Nishiyama H: Real-world treatment trends for patients with advanced prostate cancer and renal cell carcinoma and their cost-a survey in Japan. Jpn J Clin Oncol. 2024 Oct 3;54(10):1062-1070. ［5Y-IF: 2.4］

2024-45.

Ouchi M, Kitta T, Chiba H, Higuchi M, Abe-Takahashi Y, Togo M, Kusakabe N, Murai S, Kikuchi H, Matsumoto R, Osawa T, Abe T, Shinohara N: Physiotherapy for continence and muscle function in prostatectomy: a randomised controlled trial. BJU Int. 2024 Sep;134(3):398-406. ［5Y-IF: 4.5］

2024-46.

Purevdorj T, Arata M, Nii M, Yamamoto S, Noguchi H, Takeda A, Aoki H, Inui H, Kagawa T, Kinouchi R, Yamamoto Y, Yamamoto K, Iwasa T: Porcine Placental Extract Improves the Lipid Profile and Body Weight in a Post-Menopausal Rat Model Without Affecting Reproductive Tissues. Nutrients. 2025 Mar 11;17(6):984. ［5Y-IF: 5.8］

2024-47.

Sakamoto S, Sato K, Kimura T, Matsui Y, Shiraishi Y, Hashimoto K, Miyake H, Narita S, Miki J, Matsumoto R, Kato T, Saito T, Tomida R, Shiota M, Joraku A, Terada N, Suekane S, Kaneko T, Tatarano S, Yoshio Y, Yoshino T, Nishiyama N, Kawakami E, Ichikawa T, Kitamura H: PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer. Sci Rep. 2024 Jul 3;14(1):15307. ［5Y-IF: 4.3］

2024-48.

Sato M, Osawa T, Nishioka K, Miyazaki T, Takahashi S, Mori T, Hashimoto T, Miyata H, Matsumoto R, Abe T, Ohashi K, Murai S, Ito YM, Shinohara N: Decision regret after curative treatment and its association with the decision-making process and quality of life for prostate cancer patients. Int J Urol. 2025 Jan;32(1):95-102.［5Y-IF: 2.4］

2024-49.

Shiota M, Matsubara N, Kato T, Eto M, Osawa T, Abe T, Shinohara N, Nishimoto K, Yasumizu Y, Tanaka N, Oya M, Fujisawa T, Horasawa S, Nakamura Y, Yoshino T, Nonomura N: Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project. BJC Rep. 2024 Apr 3;2(1):28. ［5Y-IF: N/A］

2024-50.

Shiota M, Matsubara N, Kato T, Eto M, Osawa T, Abe T, Shinohara N, Nishimoto K, Yasumizu Y, Tanaka N, Oya M, Fujisawa T, Horasawa S, Nakamura Y, Yoshino T, Nonomura N: Prediction of undetectable circulating tumor DNA by comprehensive genomic profiling assay in metastatic prostate cancer: the SCRUM-Japan MONSTAR SCREEN project. World J Urol. 2024 Sep 18;42(1):526. ［5Y-IF: 3.1］

2024-51.

Shiota M, Takamatsu D, Matsui Y, Yokomizo A, Morizane S, Saito R, Miyake M, Tsutsumi M, Yamamoto Y, Tashiro K, Tomida R, Narita S, Edamura K, Yamaguchi T, Hashimoto K, Kato M, Kasahara T, Yoshino T, Akamatsu S, Kaneko T, Matsukawa A, Matsumoto R, Joraku A, Saito T, Kato T, Kato M, Enokida H, Sakamoto S, Terada N, Kanno H, Nishiyama N, Kimura T, Kitamura H, Eto M; Japanese Urological Oncology Group.: Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy. Ann Surg Oncol. 2024 Jun;31(6):3872-3879. ［5Y-IF: 4.0］

2024-52.

Suzuki R, Kamiyama A, Ito H, Kawashiro K, Tomiyama T, Tamura T, Suzuki A, Yoshizumi T, Hotta K, Fukuhara TJ: The Development of a Rapid, High-Throughput Neutralization Assay Using a SARS-CoV-2 Receptor. J Virol Methods. 2024 May;326:114894. ［5Y-IF: 2.0］

2024-53.

Tanegashima T, Shiota M, Kimura T, Takamatsu D, Matsui Y, Yokomizo A, Saito R, Morizane S, Miyake M, Tsutsumi M, Yamamoto Y, Tashiro K, Tomida R, Edamura K, Narita S, Yamaguchi T, Kasahara T, Hashimoto K, Kato M, Yoshino T, Akamatsu S, Matsukawa A, Kaneko T, Matsumoto R, Joraku A, Kato M, Saito T, Kato T, Tatarano S, Sakamoto S, Kanno H, Terada N, Nishiyama N, Kitamura H, Eto M; Japanese Urological Oncology Group.: Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement. Int J Clin Oncol. 2024 Oct;29(10):1586-1593.［5Y-IF: 2.8］

2024-54.

Uchishiba M, Yamamoto S, Takeda A, Arakaki R, Arata M, Noguchi H, Aoki H, Tamura K, Maeda T, Minato S, Nii M, Inui H, Kamada S, Kinouchi R, Yamamoto Y, Yoshida K, Yagi S, Kato T, Kaji T, Nishimura M, Ino K, Iwasa T: Progesterone treatment reduces food intake and body weight in ovariectomized female rats. Steroids. 2024 Mar;203:109367. ［5Y-IF: 2.4］

2024-55.

Wakabayashi N, Watanabe S, Abe T, Takenaka J, Hirata K, Kimura R, Sakamoto K, Shinohara N, Kudo K: Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis. Ann Nucl Med. 2024 Jul;38(7):553-562. ［5Y-IF: 2.3］

2024-56.

Yamamoto S, Arakaki R, Noguchi H, Takeda A, Uchishiba M, Kamada S, Mineda A, Kon M, Kinouchi R, Yamamoto Y, Yoshida K, Kaji T, Shinohara N, Iwasa T: Kisspeptin administration may promote precopulatory behavior in male rats independently or supplementally to testosterone and contribute to proceptive behavior in female partners, reducing mating failure. Gen Comp Endocrinol. 2024 Jul 1;353:114528. ［5Y-IF: 2.2］

2024-57.

Yan L, Ebina K, Abe T, Kon M, Higuchi M, Hotta K, Furumido J, Iwahara N, Komizunai S, Tsujita T, Sase K, Chen X, Kurashima Y, Kikuchi H, Miyata H, Matsumoto R, Osawa T, Murai S, Shichinohe T, Murakami S, Senoo T, Watanabe M, Konno A, Shinohara N: Validation and motion analyses of laparoscopic radical nephrectomy with Thiel-embalmed cadavers. Curr Probl Surg. 2024 Oct;61(10):101559. ［5Y-IF: 3.8］